{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:17:25Z","timestamp":1772889445099,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6_suppl_3","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2003,9,23]]},"DOI":"10.1212\/wnl.61.6_suppl_3.s17","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:17:42Z","timestamp":1336918662000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":55,"title":["Nocturnal symptom complex in PD and its management"],"prefix":"10.1212","volume":"61","author":[{"given":"K. Ray","family":"Chaudhuri","sequence":"first","affiliation":[{"name":"From the Regional Movement Disorders Unit, King\u2019s College Hospital, University Hospital Lewisham, Guy\u2019s, King\u2019s and St Thomas\u2019 School of Biomedical Medicine, King\u2019s College, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198812000-00004"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.3.341"},{"key":"e_1_3_2_4_2","first-page":"167","volume":"87","year":"1993","unstructured":"Askenasy JJ. Sleep in Parkinson\u2019s disease. Acta Neurol Scand . 1993; 87: 167\u2013170.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050404"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00541-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225070-00001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.7.1019"},{"key":"e_1_3_2_9_2","first-page":"1","volume":"46","year":"2001","unstructured":"Chaudhuri KR, Pal S, Bridgman K, Trenkwalder C. Achieving 24-hour control of Parkinson\u2019s disease symptoms; use of objective measures to improve nocturnal disability. Eur Neurol . 2001; 46 (suppl): 1","journal-title":"Eur Neurol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.1.28"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1119"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.4.540"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2000.41.2.167"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/20.9.757"},{"key":"e_1_3_2_15_2","first-page":"S218","volume":"22","year":"1999","unstructured":"Daley J, Turner RS, Bliwise DL, Rye DB. Nocturnal sleep and daytime alertness in the MPTP treated primate. Sleep . 1999; 22 (suppl): S218\u2013219.","journal-title":"Sleep"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05582-8"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.12.2253"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/14.6.540"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.8.1392"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.4.455"},{"key":"e_1_3_2_21_2","unstructured":"Fahn   S Elton   RL and members of the UPDRS Development Committee.  Unified Parkinson\u2019s disease rating scale.  In:  Fahn  S Marsden  CD Calne  D Goldstein  M eds.  Recent developments in Parkinson\u2019s disease.   Florham Park NJ:   Macmillan Healthcare Information 1987:  153\u2013163."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1971122part2397"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.2.388"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199901)14:1<117::AID-MDS1019>3.0.CO;2-0"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.2.331"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Garcia-Borreguero D Caminero AB de la Llave Y et al. Decreased phasic EMG activity during rapid eye movement sleep in treatment-na\u00efve Parkinson\u2019s disease: effects of treatment with levodopa and progression of illness. Mov Disord [serial online]. 2002; Available at: http:\/\/www.movementdisorders.org. Accessed March 12 2002.","DOI":"10.1002\/mds.10233"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199901000-00004"},{"key":"e_1_3_2_28_2","first-page":"A307.","volume":"56","year":"2001","unstructured":"Arnulf I, Konofal E, Merino-Andreau M, Bonnet AM, Mesnage V, Agid Y. Is excessive daytime sleepiness in Parkinson\u2019s disease related to poor sleep quality? An objective study of 47 patients. Neurology . 2001; 56 (suppl 3): A307.Abstract.","journal-title":"Neurology"},{"key":"e_1_3_2_29_2","unstructured":"Kryger   MH Roth   T Dement   WC.   Daytime sleepiness and alertness.  In:  Roth  T Roehrs  TA Carskadon  MA Dement  WC eds.  Principles and practice of sleep medicine.   Philadelphia:   WB Saunders 1994:  40\u201349."},{"key":"e_1_3_2_30_2","first-page":"12","volume":"5","year":"2000","unstructured":"Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson\u2019s disease. Mov Disord . 2000; 5: 12\u201321.","journal-title":"Mov Disord"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.3.465"},{"key":"e_1_3_2_33_2","first-page":"S50.","volume":"7","year":"2001","unstructured":"Pal S, Lomax C, Pezzella FR, Forbes A, Chaudhuri KR. The relationship of Parkinsonian nocturnal disability and excessive daytime sleepiness in Parkinson\u2019s disease. Parkinsonism Relat Disord . 2001; 7 (suppl): S50.Abstract.","journal-title":"Parkinsonism Relat Disord"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.2.143"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.6.629"},{"key":"e_1_3_2_36_2","unstructured":"Reuter   I Chaudhuri   KR.   The management of nocturnal disabilities in Parkinson\u2019s disease.  In:  Tod  D ed.  NAFP yearbook.   London:   Scorpio Publishing 1998:  311\u2013314."},{"key":"e_1_3_2_37_2","first-page":"32","volume":"93","year":"1993","unstructured":"Van Der Kechove, Jacquy J, Garce M, De Deyn PP. Sustained-release levodopa in parkinsonian patients with nocturnal disturbances. Acta Neurol Belg . 1993; 93: 32\u201339.","journal-title":"Acta Neurol Belg"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1999.tb00026.x"},{"key":"e_1_3_2_39_2","first-page":"8","volume":"8","year":"2001","unstructured":"Ghatani T, Agapito C, Bhattacharya K, Clough C, Chaudhuri KR. Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal \u201coff\u201d periods causing sleep disruption in Parkinson\u2019s disease. Eur J Neurol . 2001; 8 (suppl 1): 8\u201311.","journal-title":"Eur J Neurol"},{"key":"e_1_3_2_40_2","first-page":"163","volume":"100","year":"1999","unstructured":"Reuter I, Ellis CM, Chaudhuri KR. Nocturnal subcutaneous apomorphine infusion in Parkinson\u2019s disease and restless legs syndrome. Acta Neurol Scand . 1999; 100: 163\u2013167.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.11.1732"},{"key":"e_1_3_2_42_2","first-page":"360","volume":"25","year":"1999","unstructured":"Ulm G, Schuler P, on behalf of the MODAC Study Group. Carbergoline versus pergolide: a video-blinded, randomised, multicentre cross-over study. Akt Neurologie . 1999; 25: 360\u2013365.","journal-title":"Akt Neurologie"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.9.1219"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120403"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200011)15:6<1269::AID-MDS1036>3.0.CO;2-R"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H"},{"key":"e_1_3_2_47_2","first-page":"S19","volume":"58","year":"2002","unstructured":"Jankovic J. Levodopa strengths and weaknesses. Neurology . 2002; 58 (suppl 1): S19\u201332.","journal-title":"Neurology"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.1.1"},{"key":"e_1_3_2_49_2","first-page":"S3","volume":"4","year":"1997","unstructured":"Jenner PG. Is stimulation of D1 and D2 dopamine receptors important for optimal motor functioning in Parkinson\u2019s disease? Eur J Neurol . 1997; 4 (suppl 3): S3\u201311.","journal-title":"Eur J Neurol"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(93)90151-R"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.1930110509"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002210000370"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.61.6_suppl_3.S17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:16:44Z","timestamp":1711642604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.61.6_suppl_3.S17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,23]]},"references-count":51,"journal-issue":{"issue":"6_suppl_3","published-print":{"date-parts":[[2003,9,23]]}},"alternative-id":["10.1212\/WNL.61.6_suppl_3.S17"],"URL":"https:\/\/doi.org\/10.1212\/wnl.61.6_suppl_3.s17","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,23]]}}}